Tolf Bo-Ragnar 4
4 · ACADIA PHARMACEUTICALS INC · Filed Jul 9, 2009
Insider Transaction Report
Form 4
Tolf Bo-Ragnar
VP/Mg. Dir. ACADIA Pharma AB
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2009-07-08−10,000→ 15,000 totalExercise: $1.08Exp: 2013-09-07→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2009-07-08$1.08/sh+10,000$10,800→ 10,000 total - Exercise/Conversion
Common Stock
2009-07-08$1.08/sh+10,000$10,800→ 20,000 total - Exercise/Conversion
Stock Option (right to buy)
2009-07-08−10,000→ 0 totalExercise: $1.08Exp: 2013-03-16→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]25% of the shares subject to the Stock Option vested and became exercisable on March 17, 2004. The remaining shares vested and became exercisable thereafter in 36 equal monthly installments.
- [F2]25% of the shares subject to the Stock Option vested and became exercisable on September 8, 2004. The remaining shares vested and became exercisable thereafter in 36 equal monthly installments.